- Amended Current report filing (8-K/A)
July 01 2011 - 5:16PM
Edgar (US Regulatory)
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|
|
|
|
|
|
|
FORM 8-K/A
(Amendment No. 1)
|
|
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of Report
(Date of earliest event reported) July 1, 2011
AMERICAN CRYOSTEM CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Nevada
|
333-164909
|
26-4574088
|
|
|
|
(State of
incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
188 E. Bergen Pl., Suite 204, Red Bank, NJ 07701
|
|
|
|
|
(Address of principal executive offices, including
zip code)
|
|
|
|
|
(732) 747-1007
|
|
|
|
|
(Registrants telephone number, including area code)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
|
|
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
Amendment
No. 1
American
CryoStem Corporation (the
Company
),
filed a Form 8-K on April 27, 2011 (the
April
Form 8-K
) to report the acquisition of substantially all the assets
and liabilities of ACS Global, Inc., by American CryoStem Acquisition
Corporation, a wholly owned subsidiary of the Company. This amendment No. 1 to
the April Form 8-K is being filed to amend and supplement Item 9.01 of the
March Form 8-K to include the financial statements and pro forma financial
information required by parts (a) and (b) of Item 9.01 of Form 8-K.
The
Company filed a Form 8-K on June 15, 2011 relating to its adoption of amended
and restated articles of incorporation that included a change in its name its
name and another on June 27, 2011 relating to its appointment of a new
independent registered public accounting firm.
Except
as described above, all other information in and exhibits to the April Form 8-K
remain unchanged.
ITEM
9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a)
Financial
statements of businesses acquired
. Attached hereto as Exhibit 99.1, and
incorporated herein by reference, are the audited financial statements of ACS Global, Inc. for its fiscal years
ended December 31, 2010 and December 31, 2009. Attached hereto as Exhibit 99.2,
and incorporated herein by reference, are the unaudited financial statements of
ACS Global, Inc. for its
three-month period ended March 31, 2011.
(b)
Pro forma
financial information
. Attached hereto as Exhibit 99.3, and incorporated
herein by reference, is the required unaudited pro forma financial information.
(d)
Exhibits
.
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Audited Financial Statements
of ACS Global, Inc. for its
fiscal years ended December 31, 2010 and December 31, 2009
|
|
|
|
99.2
|
|
Unaudited Financial
Statements of ACS Global, Inc. for
its three-month period ended March 31, 2011
|
|
|
|
99.3
|
|
Pro Forma Financial Information
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Dated: July 1, 2011
|
|
|
|
|
AMERICAN CRYOSTEM CORPORATION
|
|
|
|
|
By:
|
/s/ John Arnone
|
|
|
|
|
|
|
Name:
|
John Arnone
|
|
Title:
|
Chairman
|
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024